Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.

Slides:

Advertisements

Similar presentations

Acid-base profile in patients on PD

Advertisements

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Buffer transport in peritoneal dialysis

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

Acid-base profile in patients on PD

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Use of icodextrin in high transport ultrafiltration failure

Volume 53, Issue 4, Pages (April 1998)

Figure 1 Changes in relative plasma volume (RPV)

Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais

Volume 57, Issue 6, Pages (June 2000)

Volume 59, Issue 1, Pages (January 2001)

Volume 55, Issue 2, Pages (February 1999)

Gentamicin pharmacokinetics during slow daily home hemodialysis

Pharmacokinetics of icodextrin in peritoneal dialysis patients

Peritoneal dialysis adequacy and risk of death

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Dmytro Khadzhynov, MD, Christian Joukhadar, MD, Harm Peters, MD

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.

Volume 60, Issue 2, Pages (August 2001)

Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.

Drug levels during the course of a dosing interval.

Quantification of free water transport in peritoneal dialysis

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

Mean and median systolic and diastolic BPs after dialysis were unchanged over time and similar between epoetin alfa-epbx and epoetin alfa. Mean and median.

Intrapatient variability in cyclosporine blood levels in renal transplant patients. Intrapatient variability in cyclosporine blood levels in renal transplant.

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Ratio of actual to expected rise in sodium as calculated using the Adrogué-Madias formula. Ratio of actual to expected rise in sodium as calculated using.

Volume 65, Issue 1, Pages (January 2004)

Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.

Dialyzer clearance of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis. Dialyzer clearance of ampicillin/sulbactam.

The International Pediatric Peritonitis Registry: Starting to walk

Ca2+ infusion rates during all three protocol versions.

Volume 59, Issue 1, Pages (January 2001)

Changes in total drug clearance with declining kidney function relates to the extent of drug clearance by the kidney. Changes in total drug clearance with.

Figure 1. Mean insulin requirement per day in 16 hemodialysis, 18 hemofiltration, 26 continuous ambulatory peritoneal dialysis (CAPD), and 14 intermittent.

A loading dose decreases the time to achieve the target concentration.

Volume 58, Issue 4, Pages (October 2000)

The timing of gentamicin administration affects the concentration-time profile in patients using hemodialysis. The timing of gentamicin administration.

Potential links between the immune dysfunction in uremia, inflammation, infection, and increased risk of atherosclerosis and cardiovascular disease. Potential.

Rates of plasma sodium concentration increase before and after DDAVP administration. Rates of plasma sodium concentration increase before and after DDAVP.

Graph showing percentage of total patients with PTD or IGT that would be detected in each category of FBG if an oral glucose tolerance test were performed.

Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.

The same daily dose of metformin administered as different dosage regimens has differing effects on the concentration–time profile in a patient with CKD.

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

Cumulative mortality risk in patients with 48-h blood urea nitrogen (BUN) levels of ≥8 mg/dl or

Rituximab immunotherapy: it’s getting personal

We identified 200 Android and 178 iOS apps using 4 search terms and narrowed this to 12 Android apps, 11 iOS apps, and 5 dual-platform apps after applying.

Relationship between excess fluid, as determined by the difference between measured and estimated body water, and plasma albumin (R = −0.40, P = 0.011).

Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.

Distribution of percent consistent facility aspirin use.

Changes in 44-hour interdialytic systolic BP as a function of change in echocardiographic volume parameter. Changes in 44-hour interdialytic systolic BP.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Dialysis limitations. Dialysis limitations. (A) Recent data from observational studies and randomized, clinical trials indicate significant limitations.

Renal replacement therapy using an in-line hemofilter during extracorporeal membrane oxygenation (ECMO). Renal replacement therapy using an in-line hemofilter.

Effect of IS on proliferation, senescence, and the production of NO and ROS from endothelial cells. Effect of IS on proliferation, senescence, and the.

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

Dose adjustments in patients with CKD are based on the change in the concentration-time profile for the drug of interest. Dose adjustments in patients.

Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.

Renal hemodynamics. Renal hemodynamics. GFR (A), effective renal plasma flow (ERPF; B), and filtration fraction (FF; C) in patients with diabetes and with.

A change in either volume of distribution or clearance has differing effects on the concentration-time profile. A change in either volume of distribution.

Mean number of dialysis sessions per patient for which intradialytic hypotension–related nursing interventions were required during the first 2 wk and.

Peritonitis treatment algorithm.

Perception of indications for referral to a nephrologist among internal medicine residents according to the postgraduate year (PGY). Perception of indications.

Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.

Presentation transcript:

Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. The figure shows the concentration–time profile of gentamicin in plasma and peritoneal dialysate of 24 peritoneal dialysis patients with peritonitis after the first dose of intraperitoneal gentamicin (0.6 mg/kg) was added to a 2-L bag of peritoneal dialysis fluid and allowed to dwell in the peritoneal cavity for 6 hours. Patients received four peritoneal dialysis fluid exchanges in a 24-hour period, with one of the dwells being the intraperitonal antibiotic dwell. During the antibiotic dwell, a decrease of gentamicin concentration in peritoneal dialysate was observed together with an increase in plasma concentration of gentamicin, which indicated systemic absorption of intraperitoneal gentamicin. During the nonantibiotic dwell time, slow elimination of gentamicin from plasma was observed, indicating a prolonged plasma elimination half-life in this patient population. Julie M. Varghese et al. CJASN 2012;7:1249-1256 ©2012 by American Society of Nephrology